ciglitazone has been researched along with Lymphoma in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Royal, W | 1 |
| Leander, M | 1 |
| Chen, YE | 1 |
| Major, EO | 1 |
| Bissonnette, RP | 1 |
1 other study available for ciglitazone and Lymphoma
| Article | Year |
|---|---|
Nuclear receptor activation and interaction with morphine.
Topics: Astrocytes; Benzoates; Cell Line; Cell Line, Tumor; Drug Interactions; Enzyme-Linked Immunosorbent A | 2004 |